Endo Reports Second-Quarter 2017 Financial Results

Go back to Endo Reports Second-Quarter 2017 Financial Results

Endo International plc (ENDP) PT Lowered to $11 at BMO Capital Following Solid 2Q

August 10, 2017 4:12 PM EDT

BMO Capital lowered its price target on Endo International plc (NASDAQ: ENDP) to $11.00 (from $15.00) while maintaining a Market Perform rating. ENDP's solid 2Q was overshadowed by its lowered guidance for 2H17 and the $775mm additional accrual to settle all outstanding mesh... More

Endo International plc (ENDP) PT Lowered to $9 at RBC Capital

August 9, 2017 7:50 AM EDT

RBC Capital lowered its price target on Endo International plc (NASDAQ: ENDP) to $9.00 (from $15.00) while maintaining a Sector Perform rating following the company's 2Q. ENDP shares traded -12% following what was a solid quarter against low expectations largely on the back heightened cash... More

Endo International plc (ENDP) PT Lowered to $9 at Cantor Fitzgerald

August 8, 2017 2:09 PM EDT

Cantor Fitzgerald lowered its price target on Endo International plc (NASDAQ: ENDP) to $9.00 (from $12.00) while maintaining a Neutral rating following the company's 2Q earnings report. ENDP reported EPS of $0.93, $0.21 above consensus. Adjusted EBITDA increased 11% to $388MM. Uncertainty regarding ENDP's earnings potential in 2018+ keeps... More

Endo Int'l (ENDP) Tops Q2 EPS by 20c, Offers FY Guidance

August 8, 2017 6:32 AM EDT

Endo Int'l (NASDAQ: ENDP) reported Q2 EPS of $0.93, $0.20 better than the analyst estimate of $0.73. Revenue for the quarter came in at $876 million versus the consensus estimate of $836.41 million.

GUIDANCE:

Endo Int'l sees FY2017 EPS of $3.35-$3.65, versus the consensus of... More